FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING...
News) - Pharmaceutical firm Vernalis PLC on Thursday said Ian Gilham is leaving his role as a non-executive director. ...
Vernalis PLC 16 August 2018 16 August 2018 LSE: VER Vernalis plc ("Vernalis" or the "Company") Board Change Vernalis plc today...
Canaccord Genuity Limited 10 August 2018 FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY...
News) - Pharmaceutical company Vernalis PLC said Thursday that it reached an agreement to be taken over by Ligand Hold ...
Ligand to gain broad portfolio of partnered and unpartnered programs, a self-funding R&D group and approximately $32 million of net...
Ligand Holdings UK Ltd 09 August 2018 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO OR...
Vernalis PLC 09 August 2018 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO OR FROM ANY...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.